TRANSACT TECHNOLOGIES INCORPORATED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (In thousands, except share data) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	AOCI Attributable to Parent [Member]	Total
Period End Date at Dec. 31, 2012	$ 109,000	$ 25,940,000	$ 24,708,000	$ (17,333,000)	$ (55,000)	$ 33,369,000
Period End Date (in Shares) at Dec. 31, 2012	8,720,200
Issuance of shares from exercise of stock options USD	$ 2,000	1,043,000				1,045,000
Issuance of shares from exercise of stock options (in Shares)	196,358
Issuance of deferred stock units		139,000				139,000
Issuance of common stock on deferred stock units, net of relinquishments		(28,000)				(28,000)
Issuance of common stock on deferred stock units, net of relinquishments shares (in Shares)	6,919
Tax benefit (charge) related to employee stock sales and vesting of restricted stock		132,000				132,000
Purchase of treasury stock				(5,194,000)		(5,194,000)
Purchase of treasury stock shares (in Shares)	(604,161)
Dividends declared and paid on common stock			(2,317,000)			(2,317,000)
Share-based compensation expense		521,000				521,000
Reversal of deferred tax asset in connection with stock options forfeited		(73,000)				(73,000)
Foreign currency translation adj., net of tax					(8,000)	(8,000)
Net income			4,935,000			4,935,000
Period End Date at Dec. 31, 2013	$ 111,000	27,674,000	27,326,000	(22,527,000)	(63,000)	32,521,000
Period End Date (in Shares) at Dec. 31, 2013	8,319,316
Issuance of shares from exercise of stock options USD		13,000				13,000
Issuance of shares from exercise of stock options (in Shares)	6,000
Issuance of deferred stock units		100,000				100,000
Issuance of common stock on deferred stock units, net of relinquishments		(44,000)				(44,000)
Issuance of common stock on deferred stock units, net of relinquishments shares (in Shares)	9,939
Tax benefit (charge) related to employee stock sales and vesting of restricted stock		7,000				7,000
Purchase of treasury stock				(2,634,000)		(2,634,000)
Purchase of treasury stock shares (in Shares)	(434,998)
Dividends declared and paid on common stock			(2,556,000)			(2,556,000)
Share-based compensation expense		506,000				506,000
Reversal of deferred tax asset in connection with stock options forfeited		(89,000)				(89,000)
Foreign currency translation adj., net of tax					(9,000)	(9,000)
Net income			(2,421,000)			(2,421,000)
Period End Date at Dec. 31, 2014	$ 111,000	28,167,000	22,349,000	(25,161,000)	(72,000)	$ 25,394,000
Period End Date (in Shares) at Dec. 31, 2014	7,900,257					11,122,293
Issuance of shares from exercise of stock options USD	$ 1,000	262,000				$ 263,000
Issuance of shares from exercise of stock options (in Shares)	34,600
Issuance of deferred stock units		160,000				160,000
Issuance of common stock on deferred stock units, net of relinquishments		(39,000)				(39,000)
Issuance of common stock on deferred stock units, net of relinquishments shares (in Shares)	13,988
Tax benefit (charge) related to employee stock sales and vesting of restricted stock		(48,000)				(48,000)
Purchase of treasury stock				(1,020,000)		(1,020,000)
Purchase of treasury stock shares (in Shares)	(166,553)
Dividends declared and paid on common stock			(2,485,000)			(2,485,000)
Share-based compensation expense		488,000				488,000
Reversal of deferred tax asset in connection with stock options forfeited		(69,000)				(69,000)
Foreign currency translation adj., net of tax					(8,000)	(8,000)
Net income			3,092,000			3,092,000
Period End Date at Dec. 31, 2015	$ 112,000	$ 28,921,000	$ 22,956,000	$ (26,181,000)	$ (80,000)	$ 25,728,000
Period End Date (in Shares) at Dec. 31, 2015	7,782,292					11,170,881